BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33855309)

  • 1. CRISPR/Cas9 ribonucleoprotein-mediated knockin generation in hTERT-RPE1 cells.
    Ghetti S; Burigotto M; Mattivi A; Magnani G; Casini A; Bianchi A; Cereseto A; Fava LL
    STAR Protoc; 2021 Jun; 2(2):100407. PubMed ID: 33855309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stem cells.
    Wang Q; Chear S; Wing K; Stellon D; Nguyen Tran MT; Talbot J; Pébay A; Hewitt AW; Cook AL
    Methods; 2021 Oct; 194():18-29. PubMed ID: 33607266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs.
    Okamoto S; Amaishi Y; Maki I; Enoki T; Mineno J
    Sci Rep; 2019 Mar; 9(1):4811. PubMed ID: 30886178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Generation of Knock-In Zebrafish Models for Inherited Disorders Using CRISPR-Cas9 Ribonucleoprotein Complexes.
    de Vrieze E; de Bruijn SE; Reurink J; Broekman S; van de Riet V; Aben M; Kremer H; van Wijk E
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
    Getachew H; Chinchilla B; Fernandez-Godino R
    Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient CRISPR/Cas9-Mediated Gene Knockin in Mouse Hematopoietic Stem and Progenitor Cells.
    Tran NT; Sommermann T; Graf R; Trombke J; Pempe J; Petsch K; Kühn R; Rajewsky K; Chu VT
    Cell Rep; 2019 Sep; 28(13):3510-3522.e5. PubMed ID: 31553918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient bi-allelic tagging in human induced pluripotent stem cells using CRISPR.
    Ren X; Takagi MA; Shen Y
    STAR Protoc; 2023 Mar; 4(1):102084. PubMed ID: 36853689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.
    Anzai T; Hara H; Chanthra N; Sadahiro T; Ieda M; Hanazono Y; Uosaki H
    Methods Mol Biol; 2021; 2320():247-259. PubMed ID: 34302663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
    Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
    STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical method for targeted disruption of cilia-related genes by using CRISPR/Cas9-mediated, homology-independent knock-in system.
    Katoh Y; Michisaka S; Nozaki S; Funabashi T; Hirano T; Takei R; Nakayama K
    Mol Biol Cell; 2017 Apr; 28(7):898-906. PubMed ID: 28179459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
    Xu H; Kita Y; Bang U; Gee P; Hotta A
    STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing.
    Artegiani B; Hendriks D; Beumer J; Kok R; Zheng X; Joore I; Chuva de Sousa Lopes S; van Zon J; Tans S; Clevers H
    Nat Cell Biol; 2020 Mar; 22(3):321-331. PubMed ID: 32123335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
    Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
    Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
    Chen S; Lee B; Lee AY; Modzelewski AJ; He L
    J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Editing in Green Alga Chlamydomonas reinhardtii via CRISPR-Cas9 Ribonucleoproteins.
    Kelterborn S; Boehning F; Sizova I; Baidukova O; Evers H; Hegemann P
    Methods Mol Biol; 2022; 2379():45-65. PubMed ID: 35188655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
    Bruntraeger M; Byrne M; Long K; Bassett AR
    Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Efficient One-Step Tagging of Endogenous Genes in Primary Cells Using CRISPR-Cas Ribonucleoproteins.
    Yao Y; Cao J; Wang W; Liu B; Pei X; Zhang L; Rao S
    CRISPR J; 2022 Dec; 5(6):843-853. PubMed ID: 36449402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein.
    Kagita A; Lung MSY; Xu H; Kita Y; Sasakawa N; Iguchi T; Ono M; Wang XH; Gee P; Hotta A
    Stem Cell Reports; 2021 Apr; 16(4):985-996. PubMed ID: 33711268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Genome Editing Using DNA-Free RNA-Guided Cas9 Ribonucleoprotein for CHO Cell Engineering.
    Shin J; Lee N; Cho S; Cho BK
    Methods Mol Biol; 2018; 1772():151-169. PubMed ID: 29754227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.